EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study

Syed Mohammad Mazidur Rahman, Pushpita Samina, Tanjina Rahman, Ahammad Shafiq Sikder Adel, Rumana Nasrin, Mohammad Khaja Mafij Uddin, Md Jahid Hasan, Shahriar Ahmed, Paul Daru, Pronab Kumar Modak, Md Abdul Hamid Salim, Sardar Munim Ibna Mohsin und 1 weitere

Clinical Microbiology and Infection · 2025

DOI: 10.1016/j.cmi.2024.09.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Syed Mohammad Mazidur Rahman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Isoniazid, Antitubercular Agents, Mycobacterium tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: USAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: In high tuberculosis (TB) burden countries such as Bangladesh, research and policy tend to focus on rifampicin (RIF)-resistant TB patients, leaving RIF-sensitive but isoniazid (INH)-resistant (Hr-TB) patients undiagnosed. Our study aims to determine the prevalence of INH resistance among pulmonary TB patients in selected health care facilities in Bangladesh. METHODS: This study was conducted across nine TB Screening and Treatment Centres situated in Bangladesh. Sputum samples from 1084 Xpert-positive pulmonary TB patients were collected between April 2021 and December 2022 and cultured for drug susceptibility testing. Demographic and clinical characteristics of Hr-TB and drug-susceptible TB patients were compared. RESULTS: Among available drug susceptibility testing results of 998 culture-positive isolates, the resistance rate of any INH regardless of RIF susceptibility was 6.4% (64/998, 95% CI: 4.9-8.2). The rate was significantly higher in previously treated (21.1%, 16/76, 95% CI: 12.0-34.2) compared with newly diagnosed TB patients (5.2%, 48/922, 95% CI: 3.8-6.9) (p < 0.001). The rate of Hr-TB was 4.5% (45/998, 95% CI: 3.3-6.0), which was also higher among previously treated patients (6.6%, 5/76, 95% CI: 1.4-13.5) compared with newly diagnosed TB patients (4.3%; 40/922, 95% CI: 3.1-5.9) (p 0.350). Most importantly, the rate of Hr-TB was more than double compared with MDR-TB (4.5%, 45/998, vs. 1.9%, 19/998) found in the current study. DISCUSSION: This study reveals a high prevalence of Hr-TB, surpassing even that of the multi-drug-resistant TB in Bangladesh. This emphasizes the urgent need to adopt WHO-recommended molecular tools at the national level for rapid detection of INH resistance so that patients receive timely and appropriate treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PulmonaryIsoniazidAntitubercular AgentsMycobacterium tuberculosisTuberculosis, Multidrug-ResistantDrug Resistance, BacterialHumansBangladeshMaleFemaleAdultMiddle AgedMicrobial Sensitivity TestsYoung AdultPrevalenceSputumRifampinAdolescentAged

Stichwörter der Autor:innen

BangladeshIsoniazidPulmonary tuberculosisRIF sensitive but INH-Resistant TBResistance pattern

Substanzen

IsoniazidAntitubercular AgentsRifampin

Autor:innen und Institutionen

  • Infectious Diseases Division, icddr,b, Dhaka, Bangladesh.
  • Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada.
  • National Tuberculosis Control Programme, Dhaka, Bangladesh.
  • USAID STAR Program, National Tuberculosis Control Programme, Dhaka, Bangladesh.
  • US Agency for International Development (USAID), Dhaka, Bangladesh.
  • Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. Electronic address: sbanu@icddrb.org.

Förderung

  • USAID

Zitieren

APA

Rahman, S. M. M., Samina, P., Rahman, T., Adel, A. S. S., Nasrin, R., Uddin, M. K. M., Hasan, M. J., Ahmed, S., Daru, P., Modak, P. K., Salim, M. A. H., Mohsin, S. M. I., & Banu, S. (2025). Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.09.027

Vancouver

Rahman SMM, Samina P, Rahman T, Adel ASS, Nasrin R, Uddin MKM, et al. Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2024.09.027

BibTeX
@article{Rahman2025,
  author = {Rahman, Syed Mohammad Mazidur and Samina, Pushpita and Rahman, Tanjina and Adel, Ahammad Shafiq Sikder and Nasrin, Rumana and Uddin, Mohammad Khaja Mafij and Hasan, Md Jahid and Ahmed, Shahriar and Daru, Paul and Modak, Pronab Kumar and Salim, Md Abdul Hamid and Mohsin, Sardar Munim Ibna and Banu, Sayera},
  title = {Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study},
  journal = {Clinical Microbiology and Infection},
  year = {2025},
  doi = {10.1016/j.cmi.2024.09.027}
}
Kostenlos starten →